The Baker Bros. purchase cluster signals strong insider alignment with the company's post-earnings trajectory. Monitor next quarter's Rezdiffra sales trajectory and the MAESTRO-CSPH trial enrollment for sustained revenue growth.
MDGL drugs
MDGL drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $432.79entry
- T+1 · 7d ago −0.04%α +0.32% · $432.60
- T+5 · 20h ago −2.04%α −0.35% · $423.96
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Baker Bros. Advisors, a director and top institutional holder, made a $2.05M open-market purchase of MDGL on Nov 4, 2026, following the company's Q3 earnings report (Nov 3) showing 50% YoY revenue growth to $431.3M and first-ever quarterly profitability. The purchase is part of a larger cluster of Baker Bros. buys totaling ~$35M over the past week, reinforcing insider conviction after strong results.
Key Financial Metrics
Key Facts
- Baker Bros. Advisors LP (Director) purchased 5,586 shares at $366.99 on Nov 4, 2026, total $2.05M
- Purchase is open-market (code P), not under a 10b5-1 plan
- Q3 2026 revenue $431.3M (50% YoY growth), first profitable quarter with net income $55.4M ($1.83 EPS)
- Baker Bros. is the largest institutional holder at $1.2B (13F Q2 2026)
- Total Baker Bros. purchases in the cluster (Nov 4-6) exceed $35M
- Market cap $9.3B; purchase represents ~0.022% of market cap
- General Counsel sold $431K on Nov 6, a routine and immaterial sale
Financial Impact
$2.05M open-market purchase by top holder post-strong earnings
Risk Factors
- Single insider purchase, albeit by largest holder, does not guarantee future performance
- General Counsel's small sale is routine and not a counter-signal
- Dependence on Rezdiffra for nearly all revenue creates concentration risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001193125-26-452132 |
Track record
18 reports on MDGL
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $424.08 Now $423.96 −0.03% settles Nov 23
- Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Buy Bullish 5/10 Viewing Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
- Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers